Shoji Hirashima

Shoji Hirashima

Chairman at

Sankyo Pharma GmbH

64 year

Distribution Services

Health Technology

News on Shoji Hirashima

Daiichi Sankyo : Announces Appointments of Directors and Audit & Supervisory Board Members(265.9KB	16/23/16	PU
Kite and Daiichi Sankyo Announce Changes to YESCARTA CAR T-Cell Therapy Licensing Agreement in Japan	08/22/08	AQ
Daiichi Sankyo : Announces Changes to Representative Directors, Directors and Audit & Supervisory Board Members	13/21/13	PU
Daiichi Sankyo Company, Limited Appoints New Corporate Officers, Effective April 1, 2021	22/21/22	CI
Daiichi Sankyo : Appoints New Group Corporate Officers	22/19/22	PU
Daiichi Sankyo Company, Limited Announces New Group Corporate Officers Effective from April 1, 2019	22/19/22	CI
Daiichi Sankyo Company, Limited Appoints New Group Corporate Officers	24/17/24	CI
Daiichi Sankyo : Appoints New Group Corporate Officers	24/17/24	PU

Linked companies

Listed companies	1
DAIICHI SANKYO COMPANY, LIMITED	Health Technology

Private companies	1
Sankyo Pharma GmbH Sankyo Pharma GmbH Medical DistributorsDistribution Services Part of Daiichi Sankyo Co., Ltd., Sankyo Pharma GmbH is a German pharmaceutical distribution company. The company is based in Munich, Germany. Jan van Ruymbeke has been the CEO of the company since 2012.	Distribution Services

See company connections

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

+89%* on our US portfolio vs. 52% on the S&P 500 net Total Return

Replicate our performance

Replicate our performance